澳股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

醫藥生物股

714.764

-4.169-0.58%

漲家數：17

跌家數：11

平家數：17

市盈率：- -

高：721.437

開：718.050

低：714.076

收：718.933

成交量：4,302.41萬

成交額：2.50億

市值：1,082.75億

流通市值：1,051.43億

資料載入中...

Imricor Medical Systems Inc成功完成FDA審批通道內所有設備的人因工程研究

CSL Ltd：Varmx將獲得高達3.88億美元付款直至Vmx-C001上市，後續還有商業里程碑獎勵

CSL LIMITED將向Varmx支付1.17億美元預付款，獲得收購該公司的獨家選擇權

CSL LIMITED簽署協議開發新療法幫助Fxa抑制劑患者恢復血液凝固功能

Actinogen：FDA同意僅需進行一項額外的關鍵試驗，採用單一10毫克Xanamem劑量設計對比安慰劑的阿爾茨海默病試驗

Actinogen Medical Ltd計劃於2026年與歐洲藥品管理局就阿爾茨海默病項目舉行會議

Actinogen Medical Ltd與FDA達成協議，就Xanamem阿爾茨海默病藥物未來美國上市審批所需的製造、臨牀及非臨牀活動事宜舉行C類會議

Bioxyne Ltd獲得德國政府批准進口1,550公斤醫用大麻產品

Immutep宣佈Eftisarc-Neo II期試驗數據獲CTOS 2025大會口頭報告接受該試驗評估Efti在軟組織肉瘤中的新輔助療法

MAYNE PHARMA GROUP LTD - 此前並未被告知與南澳州長或其辦公室與Cosette之間的任何對話或溝通

Gate將上線Hyperbot (BOT) 並開啓系列活動

幣安公佈Hyperbot(BOT)TGE參與門檻為231 Alpha積分

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK7508/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK7508","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","market":"AU","secType":"PLATE","nameCN":"醫藥生物股","latestPrice":714.76434,"timestamp":1758175199611,"preClose":718.9331,"halted":0,"volume":43024083,"delay":0,"changeRate":-0.005799,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盤","change":-4.168762,"latestTime":"09-18 16:00:00 AEST","open":718.05005,"high":721.43744,"low":714.0763,"amount":249638907,"amplitude":0.010239,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1758240000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1758153600000,1758175200000]],"turnoverRate":0.00154,"increases":20,"decrements":13,"flats":11,"marketCap":108275111949.75,"floatMarketCap":105142501769.4375},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","high":721.43744,"amplitude":0.010239,"preClose":718.9331,"low":714.0763,"latestPrice":714.76434,"volume":43024083,"delay":0,"open":718.05005,"prevYearClose":936.801,"prevWeekClose":740.889,"prevMonthClose":762.058,"prevQuarterClose":795.022,"fiveDayClose":733.285,"twentyDayClose":798.289,"sixtyDayClose":793.519,"secType":"PLATE","market":"AU","turnoverRate":0.00154,"marketCap":108275111949.75,"floatMarketCap":105142501769.4375,"timestamp":1758175199611,"nameCN":"醫藥生物股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK7508\",,,,undefined,":{"bkCode":"BK7508","up":17,"down":11,"flat":17},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK7508\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1199473456","title":"Imricor Medical Systems Inc成功完成FDA審批通道內所有設備的人因工程研究","url":"https://stock-news.laohu8.com/highlight/detail?id=1199473456","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199473456?lang=zh_tw&edition=fundamental","pubTime":"2025-09-18 06:55","pubTimestamp":1758149714,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems Inc宣布已成功完成其FDA审批通道内所有医疗设备的人因工程研究。\n该项研究的顺利完成标志着公司在获得美国食品药品监督管理局(FDA)批准方面迈出了重要一步，为其医疗设备产品的商业化进程奠定了坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7503","IMR.AU","BK7508","BK7007"],"gpt_icon":0},{"id":"1139501060","title":"CSL Ltd：Varmx將獲得高達3.88億美元付款直至Vmx-C001上市，後續還有商業里程碑獎勵","url":"https://stock-news.laohu8.com/highlight/detail?id=1139501060","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139501060?lang=zh_tw&edition=fundamental","pubTime":"2025-09-16 06:03","pubTimestamp":1757973797,"startTime":"0","endTime":"0","summary":"CSL Ltd宣布，Varmx将获得高达3.88亿美元的付款，该付款将持续到Vmx-C001产品上市为止，此外在产品上市后还将根据进一步的商业里程碑获得额外付款。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSL.AU","BK7067","BK7511","BK7508","BK7501"],"gpt_icon":0},{"id":"1114789203","title":"CSL LIMITED將向Varmx支付1.17億美元預付款，獲得收購該公司的獨家選擇權","url":"https://stock-news.laohu8.com/highlight/detail?id=1114789203","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114789203?lang=zh_tw&edition=fundamental","pubTime":"2025-09-16 06:03","pubTimestamp":1757973797,"startTime":"0","endTime":"0","summary":"CSL LIMITED宣布将向Varmx公司支付1.17亿美元的预付款，以获得收购该公司的独家选择权。这笔预付款将为CSL LIMITED提供独家权利，可在未来决定是否正式收购Varmx公司。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSL.AU","BK7511","BK7067","BK7508","BK7501"],"gpt_icon":0},{"id":"1146117468","title":"CSL LIMITED簽署協議開發新療法 幫助Fxa抑制劑患者恢復血液凝固功能","url":"https://stock-news.laohu8.com/highlight/detail?id=1146117468","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146117468?lang=zh_tw&edition=fundamental","pubTime":"2025-09-16 06:03","pubTimestamp":1757973796,"startTime":"0","endTime":"0","summary":"CSL LIMITED与合作方达成开发协议，将致力于研发一种创新治疗方案，旨在为正在使用Fxa抑制剂的患者恢复血液凝固能力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSL.AU","BK7508","BK7067","BK7511","BK7501"],"gpt_icon":0},{"id":"1186330080","title":"Actinogen：FDA同意僅需進行一項額外的關鍵試驗，採用單一10毫克Xanamem劑量設計對比安慰劑的阿爾茨海默病試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=1186330080","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186330080?lang=zh_tw&edition=fundamental","pubTime":"2025-09-15 20:44","pubTimestamp":1757940254,"startTime":"0","endTime":"0","summary":"Actinogen：FDA同意仅需进行一项额外的关键试验，采用单一10毫克Xanamem剂量设计对比安慰剂的阿尔茨海默病试验","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7067","ACW.AU"],"gpt_icon":0},{"id":"1164379463","title":"Actinogen Medical Ltd計劃於2026年與歐洲藥品管理局就阿爾茨海默病項目舉行會議","url":"https://stock-news.laohu8.com/highlight/detail?id=1164379463","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164379463?lang=zh_tw&edition=fundamental","pubTime":"2025-09-15 20:42","pubTimestamp":1757940178,"startTime":"0","endTime":"0","summary":"Actinogen Medical Ltd计划于2026年与欧洲药品管理局就阿尔茨海默病项目举行会议。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACW.AU","BK7067","BK7508"],"gpt_icon":0},{"id":"1157388737","title":"Actinogen Medical Ltd與FDA達成協議，就Xanamem阿爾茨海默病藥物未來美國上市審批所需的製造、臨牀及非臨牀活動事宜舉行C類會議","url":"https://stock-news.laohu8.com/highlight/detail?id=1157388737","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157388737?lang=zh_tw&edition=fundamental","pubTime":"2025-09-15 20:30","pubTimestamp":1757939416,"startTime":"0","endTime":"0","summary":"Actinogen Medical Ltd与FDA在C类会议中就其阿尔茨海默病治疗药物Xanamem未来在美国市场获得批准所需的制造、临床和非临床活动达成了协议。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","ACW.AU","BK7067"],"gpt_icon":0},{"id":"1121769081","title":"Bioxyne Ltd獲得德國政府批准進口1,550公斤醫用大麻產品","url":"https://stock-news.laohu8.com/highlight/detail?id=1121769081","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121769081?lang=zh_tw&edition=fundamental","pubTime":"2025-09-15 07:10","pubTimestamp":1757891415,"startTime":"0","endTime":"0","summary":"Bioxyne Ltd已获得德国政府的进口授权，允许进口1,550公斤医用大麻产品。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BXN.AU","BK7111","BK7508"],"gpt_icon":0},{"id":"1158451855","title":"Immutep宣佈Eftisarc-Neo II期試驗數據獲CTOS 2025大會口頭報告接受 該試驗評估Efti在軟組織肉瘤中的新輔助療法","url":"https://stock-news.laohu8.com/highlight/detail?id=1158451855","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158451855?lang=zh_tw&edition=fundamental","pubTime":"2025-09-08 20:01","pubTimestamp":1757332877,"startTime":"0","endTime":"0","summary":"Immutep宣布，其Eftisarc-Neo II期临床试验的数据已被CTOS 2025大会接受进行口头报告展示。该试验主要评估新辅助疗法Efti在软组织肉瘤治疗中的效果。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMM.AU","BK7508","BK7067"],"gpt_icon":0},{"id":"1106865271","title":"MAYNE PHARMA GROUP LTD - 此前並未被告知與南澳州長或其辦公室與Cosette之間的任何對話或溝通","url":"https://stock-news.laohu8.com/highlight/detail?id=1106865271","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106865271?lang=zh_tw&edition=fundamental","pubTime":"2025-09-08 07:03","pubTimestamp":1757286193,"startTime":"0","endTime":"0","summary":"MAYNE PHARMA GROUP LTD此前并未被告知与南澳州长或其办公室与Cosette之间的任何对话或沟通。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","MYX.AU","BK7096"],"gpt_icon":0},{"id":"2564398997","title":"Gate將上線Hyperbot (BOT) 並開啓系列活動","url":"https://stock-news.laohu8.com/highlight/detail?id=2564398997","media":"Odaily","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564398997?lang=zh_tw&edition=fundamental","pubTime":"2025-09-03 19:53","pubTimestamp":1756900382,"startTime":"0","endTime":"0","summary":"<div class=\"line-clamp-4 text-custom-000000/70 dark:text-custom-FFFFFF/60 text-18 font-400 tracking-1 leading-40 whitespace-pre-line\"><p>Odaily星球日报讯 据官方公告，Gate 将于 9 月 3 日 21:00 (UTC+8) 上线 Hyperbot (BOT) 现货交易。并将于 21:10 (UTC+8) 开启 Hyperbot (BOT) 永续合约交易，支持 1-20 倍杠杆。</p><p>同时，杠杆借贷交易将于 9 月 3 日 21:10 (UTC+8) 开启。此外，交易机器人、跟单、闪兑、定投功能将在现货交易开启 1 小时后陆续上线。为回馈平台用户，Gate 重磅推出 Launchpool 及 Candydrop 活动。</p><p>Gate Launchpool 将于 9 月 3 日 21:00 至 9 月 24 日 21:00 (UTC+8) 开启第 308 期 Launchpool 活动。用户质押 GUSD、BOT 即可分享 6,500,000 BOT。</p><p>Gate CandyDrop 将于 9 月 3 日 21:10 至 9 月 15 日 21:00 (UTC+8) 开启 CandyDrop 第 77 期： CandyDrop x Hyperbot (BOT)，用户通过完成合约首次交易、现货交易及邀请好友等任务，即可参与分配 2,000,000 BOT 奖池，单人上限 1,100 BOT。</p></div>","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.odaily.news/zh-CN/newsflash/446393","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"odaily_live","symbols":["BK7502","BOT.AU","BK7508","BK7096"],"gpt_icon":0},{"id":"2564354987","title":"幣安公佈Hyperbot(BOT)TGE參與門檻為231 Alpha積分","url":"https://stock-news.laohu8.com/highlight/detail?id=2564354987","media":"金色财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564354987?lang=zh_tw&edition=fundamental","pubTime":"2025-09-03 13:55","pubTimestamp":1756878951,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.binance.com/zh-CN/square/post/29177571012946","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinse_live","symbols":["BK4206","BK7096","TGE","BOT.AU","BK7502","BK7508"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":12,"code":"91000000","status":"200"}]}}